MedTrace Logo

Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients

NCT01866904 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 9284

Last updated 2018-09-04

No results posted yet for this study

Summary

THis study is intended to provide contemporary data on the burden of disease in patients 1 to 3 years post-MI, including a description of patient characteristics, current treatment patterns, rate of major CV events, and healthcare resource utilization in a 'real world' patient population at high atherothrombotic risk.

Conditions

  • Stable Coronary Artery Disease (CAD), Myocardial Infarction

Sponsors & Collaborators

Principal Investigators

  • Lin Zhang, M.D., PhD · AstraZeneca GMA

  • David Brieger, MBBS, PhD · Concord Repatriation General Hospital

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-19
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • United States
  • Argentina
  • Australia
  • Belgium
  • Brazil
  • Canada
  • China
  • Colombia
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Mexico
  • Netherlands
  • Norway
  • Portugal
  • Romania
  • South Korea
  • Spain
  • Turkey (Türkiye)
  • United Kingdom
  • Venezuela

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01866904 on ClinicalTrials.gov